emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

Synergetics USA / Sterimedix

No EMAT : 75874
Announced Date : 10/12/2014
Type : Acquisition of Majority Stake
Deal Value : Yes
Acquirer : Synergetics USA

Target : Sterimedix
Country : United Kingdom
Sector of activity :
  • Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Medical Supplies
Business Description :
Founded in 1989, Sterimedix manufactures and markets single-use devices for ophthalmic surgery and non-surgical aesthetic procedures in the United Kingdom. > Offers a range of cannulas, handpieces,...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic
Current
Rating : **
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Medical Supplies » = 73
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
06/11/2014 Perrigo Co Omega Pharma Belgium *** 75832
28/10/2015 Karo Bio MedCore Sweden ** 75827

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report